Compounds for the treatment of metabolic disorders

Details for Australian Patent Application No. 2010222673 (hide)

Owner Prosidion Limited

Inventors Barba, Oscar; Davis, Susan Helen; Fyfe, Matthew Colin Thor; Jeevaratnam, Revathy Perpetua; Schofield, Karen Lesley; Staroske, Thomas; Stewart, Alan John William; Swain, Simon Andrew; Withall, David Matthew

Agent Watermark

Pub. Number AU-A-2010222673

PCT Pub. Number WO2010/103335

Priority 0904287.0 12.03.09 GB

Filing date 12 March 2010

Wipo publication date 16 September 2010

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/103335 Priority application(s): WO2010/103335

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010222683-Process for the preparation of bosentan

2010222672-Compounds for the treatment of metabolic disorders